These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33535892)

  • 1. Expression defect of the rare variant/Brugada mutation R1512W depends upon the SCN5A splice variant background and can be rescued by mexiletine and the common polymorphism H558R.
    Hu RM; Song EJ; Tester DJ; Deschenes I; Ackerman MJ; Makielski JC; Tan BH
    Channels (Austin); 2021 Dec; 15(1):253-261. PubMed ID: 33535892
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine.
    Tan BH; Valdivia CR; Song C; Makielski JC
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1822-8. PubMed ID: 16632547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmogenic Biophysical Phenotype for SCN5A Mutation S1787N Depends upon Splice Variant Background and Intracellular Acidosis.
    Hu RM; Tan BH; Tester DJ; Song C; He Y; Dovat S; Peterson BZ; Ackerman MJ; Makielski JC
    PLoS One; 2015; 10(4):e0124921. PubMed ID: 25923670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del.
    Cheng J; Morales A; Siegfried JD; Li D; Norton N; Song J; Gonzalez-Quintana J; Makielski JC; Hershberger RE
    Clin Transl Sci; 2010 Dec; 3(6):287-94. PubMed ID: 21167004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biophysical characterization of the first SCN5A mutation R1512W identified in Chinese sudden unexplained nocturnal death syndrome.
    Zheng J; Zhou F; Su T; Huang L; Wu Y; Yin K; Wu Q; Tang S; Makielski JC; Cheng J
    Medicine (Baltimore); 2016 Jun; 95(23):e3836. PubMed ID: 27281089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.
    Nakajima T; Dharmawan T; Kawabata-Iwakawa R; Tamura S; Hasegawa H; Kobari T; Ota M; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12828. PubMed ID: 33463855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants.
    Tan BH; Valdivia CR; Rok BA; Ye B; Ruwaldt KM; Tester DJ; Ackerman MJ; Makielski JC
    Heart Rhythm; 2005 Jul; 2(7):741-7. PubMed ID: 15992732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
    PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels.
    Makielski JC; Ye B; Valdivia CR; Pagel MD; Pu J; Tester DJ; Ackerman MJ
    Circ Res; 2003 Oct; 93(9):821-8. PubMed ID: 14500339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients.
    Hu RM; Tester DJ; Li R; Sun T; Peterson BZ; Ackerman MJ; Makielski JC; Tan BH
    Channels (Austin); 2018; 12(1):176-186. PubMed ID: 29983085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
    Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
    Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
    Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of sodium current caused by a Brugada syndrome-associated variant is determined by patient-specific genetic background.
    Martínez-Moreno R; Carreras D; Sarquella-Brugada G; Pérez GJ; Selga E; Scornik FS; Brugada R
    Heart Rhythm; 2024 Mar; 21(3):331-339. PubMed ID: 38008367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.
    Nasilli G; Yiangou L; Palandri C; Cerbai E; Davis RP; Verkerk AO; Casini S; Remme CA
    Europace; 2023 Jun; 25(6):. PubMed ID: 37369559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H558R, a common SCN5A polymorphism, modifies the clinical phenotype of Brugada syndrome by modulating DNA methylation of SCN5A promoters.
    Matsumura H; Nakano Y; Ochi H; Onohara Y; Sairaku A; Tokuyama T; Tomomori S; Motoda C; Amioka M; Hironobe N; Toshishige M; Takahashi S; Imai K; Sueda T; Chayama K; Kihara Y
    J Biomed Sci; 2017 Dec; 24(1):91. PubMed ID: 29202755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.
    Zhang J; Chen Y; Yang J; Xu B; Wen Y; Xiang G; Wei G; Zhu C; Xing Y; Li Y
    Eur J Pharmacol; 2015 Jan; 746():333-43. PubMed ID: 25261036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mutation causing Brugada syndrome identifies a mechanism for altered autonomic and oxidant regulation of cardiac sodium currents.
    Aiba T; Farinelli F; Kostecki G; Hesketh GG; Edwards D; Biswas S; Tung L; Tomaselli GF
    Circ Cardiovasc Genet; 2014 Jun; 7(3):249-56. PubMed ID: 24795344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The common African American polymorphism SCN5A-S1103Y interacts with mutation SCN5A-R680H to increase late Na current.
    Cheng J; Tester DJ; Tan BH; Valdivia CR; Kroboth S; Ye B; January CT; Ackerman MJ; Makielski JC
    Physiol Genomics; 2011 May; 43(9):461-6. PubMed ID: 21385947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
    Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C
    Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.